Cholera is preventable and treatable acute diarrhoeal disease caused by infection of the intestine with the bacterium Vibrio cholerae, either serogroup O1 or O139. Cholera is usually transmitted through consumption of water or food contaminated by faeces bearing the cholera organism.
This study focused on risk factors for contracting malaria and access to health centre/hospital-based healthcare services by making a comparison of the Batwa indigenous people and their non-Batwa neighbours in Kanungu district. The researcher investigated how the two independent variables namely: risk factors for contracting malaria and health seeking behaviour of the two population groups impinged on the dependent variable: access to health centre/hospital-based case management of malaria.
This chapter presents the following sections: a background to the study which sets the context to the problem under study, statement of the problem, objectives of the study, research questions, significance of the study, conceptual framework,
The goal of this tuberculosis (TB) infection control guidelines is to guide management staff, including health care workers, congregate settings managers and household heads to minimize the risk of TB transmission at Ugandan facilities in particular and the whole country in general. The current national infection control guidelines (2005) is silent on TB infection control measures. This guideline has been designed to address this gap and therefore is an addendum to the 2005 national infection control guideline.
Conventional light microscopy of Ziehl-Neelsen-stained smears prepared directly from sputum specimens is the most widely available test for diagnosis of tuberculosis (TB) in resource-limited settings. Ziehl-Neelsen microscopy is highly specific, but its sensitivity is variable (20–80%) and is significantly reduced in patients with extrapulmonary TB and in HIV-infected TB patients. Conventional fluorescence microscopy is more sensitive than Ziehl-Neelsen and takes less time, but its use has been limited by the high cost of mercury vapour light sources, the need for regular maintenance and the requirement for a dark room.
At the centre of an ever-strengthening HIV/AIDS storm, young people aged 15 to 24 now make up more than one quarter of the 38 million people living with the disease. More than half of the 5 million new infections in 2003 were among people under the age of 25.
The majority of these new infections were among young women, who, for reasons typically beyond their control, are at greater risk of contracting HIV, and who, for reasons most fully explained by gender disparities, bear a disproportionate share of the HIV/AIDS burden.
The global community has embarked on an historic quest to lay the foundation for the eventual end of the AIDS epidemic. This effort is more than merely visionary. It is entirely feasible. Unprecedented gains have been achieved in reducing the number of both adults and children newly infected with HIV, in lowering the numbers of people dying from AIDS-related causes and in implementing enabling policy frameworks that accelerate progress. A new era of hope has emerged in countries and communities across the world that had previously been devastated by AIDS.
The purpose of this document is to provide guidance to national AIDS programmes and partners on the use of indicators to measure and report on the country response.
The purpose of this document is to provide guidance to national AIDS programmes and partners actively involved in the country response to AIDS on use of core indicators to measure and report on the national response.The “2011 UN Political Declaration on HIV/AIDS: Intensifying our Efforts to Eliminate HIV/AIDS” (General Assembly resolution 65/277), which was adopted at the United Nations General Assembly High Level Meeting on AIDS in June 2011, mandated UNAIDS to support countries to report on the commitments in the 2011 UN Political Declaration on HIV/AIDS. In addition the 2011 Political Declaration called for a special report to the General Assembly on progress in accordance with global reporting on the Millennium Development Goals in the 2013 review of the Goals.
The purpose of this document is to provide guidance to national AIDS programmes and partners actively involved in the country response to AIDS on use of core indicators to measure and report on the national response.
The world has committed to ending the AIDS epidemic by 2030. How to reach this bold target within the Sustainable Development Goals is the central question facing the United Nations General Assembly High-Level Meeting on Ending AIDS, to be held from 8 to 10 June 2016. The extraordinary accomplishments of the last 15 years have inspired global confidence that this target can be achieved.
Since mid 1990’s, WHO and partners have provided technical support to a large number of African countries to promote rational use of antimalarial medicines, monitor medicine efficacy and update treatment policies. In Uganda, resistance of Plasmodium falciparum to Chlororoquine rose to unacceptable levels compelling government to institute an interim malaria treatment policy in 2002. The interim policy recommended a combination treatment composed of Chloroquine and Sulfadoxine/Pyrimethamine (Fansider) as the first line treatment. Unfortunately, resistance to the antimalarial medicines persisted, leading to another change of policy in 2004. The new policy adopted Artemisinin-based Combination Treatment (ACT) as the first line treatment for malaria in Uganda. This was in line with the current WHO recommendation of use of combination therapies, particularly those containing an artemesinin based compound1.
This report covers the experiences and lessons learned during the distribution of free long lasting insecticidal nets (LLINs) to nine UPHOLD supported districts between December 2005 and March 2006, using the existing Home-based Management of Fever (HBMF) system as the distribution channel.
